UBS Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri through a formal and a fireside presentations and a series...
Read moreDario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From encoded combinatorial libraries to clinical-stage radiopharmaceuticals”
Philogen announces its attendance at the Peptide Therapeutic Forum 2022. Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled “Small Molecule Therapeutics as an alternative...
Read morePhilogen kindly invites you to attend a virtual briefing for analysts on 1 April 2022 to discuss the Company’s Full Year 2021 Financial Results. Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura...
Read morePhilogen announces its attendance at the workshop “Il Sistema Ricerca-Industria in Italia” at Accademia dei Lincei (Rome, Italy). Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From...
Read moreDario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From encoded combinatorial libraries to clinical-stage targeted therapeutics”